Nyxoah SA Ordinary Shares
NYXHStockNASDAQ
$1.39 ▼ 6.71%
12 juin 2026
N
Nyxoah SA Ordinary Shares
$1.39 ▼ 6.71%
12 juin 2026
NYXHStockNASDAQ

01 / À propos

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Arberion
Loading market data